secwatch.observer — SEC 8-K summary
======================================

Issuer:     Evofem Biosciences, Inc. (EVFM)
CIK:        0001618835
Form:       8-K
Filed at:   2025-07-02T23:59:59+00:00
Accession:  0001641172-25-017563
Event type: debt
Sentiment:  negative
Materiality: 0.70
Item codes: 1.01, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Evofem Biosciences issues $1.42M convertible notes and warrants to Aditxt
-------------------------------------------------------------------------

- Aggregate principal amount $1,423,076.92; warrants to purchase 92,407,592 shares.
- Aditxt paid ~$650 per $1,000 principal; net proceeds ~$925,000.
- Notes bear 8% interest (12% upon default), mature June 26, 2028.
- Conversion/exercise price $0.0154 per share; 9.99% beneficial ownership cap.
- Warrants exercisable immediately, expire in 5 years, allow cashless exercise.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1618835/000164117225017563/0001641172-25-017563-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1618835/000164117225017563/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001641172-25-017563

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer